About PCR

PCR - Sharing knowledge, experience and practice in cardiovascular interventional medicine.

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. Its activities cover a large spectrum, from the organisation of annual courses in Europe, Asia and the Middle East to editing a scientific journal, publishing textbooks as well as providing training sessions and online courses on thematic subjects. Courses are based on themes like Coronary Interventions, Hypertension and Stroke, Peripheral Interventions, Valvular Disease and Heart Failure.

The PCR Courses include: AfricaPCRAsiaPCR/SingLIVE, EuroPCR, GulfPCR-GIM, PCH (Practical Course on Hypertension), PCR-CIT China Chengdu Valves, PCR Clinical Research, PCR edu online, PCR Innovators Day, PCR London Valves, PCR Peripheral, PCR Seminars, PCR Tokyo Valves

Find both informative and educative material, archives and the latest updates from the fast-evolving world of cardiovascular medicine.

Join us!

The information provided on PCRonline.com is designed to support, not replace, the relationship that exists between a patient/site visitor and their physicians. Create your MyPCR account, it's FREE!

Filter By

69 results

Questions & answers for participants

Exchanges between industry members, Healthcare Professionals and Healthcare Organisations are evolving under new regulations advanced/adopted by several regional organisations (MedTech Europe, APACMed, Mecomed) which have come into force on 01 January 2018. What exactly does this mean for Healthcare Professionals?

Questions & answers for Industry Partners

Exchanges between industry, Healthcare Professionals and Healthcare Organisations (including Professional Congress Organisers - PCO) are evolving under new regulations which have come into force on 1st January 2018. What exactly does this mean for Industry Partners? How can they get on board with these changes? Your most frequently asked questions are answered in this section.

First in human implantation of a novel transfemoral self-expanding transcatheter heart valve to treat pure aortic regurgitation

The first case of a novel JenaValve design using the transfemoral approach in a 78 year old female patient with pure aortic regurgitation is described in this article.

Authors :

Ulrich Schaefer, Johannes Schirmer, Schofer Niklas, Eva Harmel, Florian Deuschl and Lenard Conradi

Aortic stenosis prevalence and balloon aortic valvuloplasty publish

The transformation in the field of interventional cardiology is unprecedented. Since the late 1970's, rapid changes have taken place, and today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab. The field was initially driven by the treatment of the vasculature system, but has expanded over the last 15 years to structural heart disease.

First FIM Percutaneously Implanted Heart Valve (PHV) implantation on 16 April, 2002

On April 16, 2002, at the Charles Nicolle University Hospital in Rouen, France, the Interventional Cardiologist, Professor Alain Cribier performed the first transcatheter aortic valve replacement procedure in the world. He used a Prosthetic valve thrombosis (PVT) percutaneous heart valve.

Prof. Alain Cribier


Alain Cribier

Alain G. Cribier

Alain Cribier, M.D., FACC, FESC (born in 1945) is a French interventional cardiologist and is a Professor of Medicine and Director of Cardiology at the University of Rouen's Charles Nicolle Hospital, France.

As part of celebrating the 15th year of TAVI, we are presenting a summary of Alain Cribier’s career highlights and quests.This page is dedicated to the personal life and accomplishments.

Indirect Educational Sponsorship

The new MedTech Europe Code of Ethics, echoed by regional counterparts (APACMed, Mecomed), has come into force since 1st January 2018. Set to regulate interactions between industries, Healthcare Professionals and Healthcare Organisations (ex: learned societies, conference organisers, associations, et al.), this Code prevents improper perceptions regarding funding support and/or various actions taken by industries in the context of third-party organised events. Concretely:

In accordance with the new Code, Industry partners wishing to sponsor participants attendance to educational events must comply with an indirect sponsorship scheme. Sponsorship is to be offered in the form of Educational Allowances attributed through trusted-third-parties, such as:Healthcare institutions: it is highly recommended for practitioners to contact their institution in order to get further information on grant availabilities within it.Europa Group/PCR, which is equipped to receive funds from Industry Partners and allocate Educational Allowances to participants. Only if and when available, participants will be notified of grant possibilities via email. Contact shall be made using the information provided by practitioners in their MyPCR accounts.

The new regulation has come into force on 1 January 2018.

What is MedTech Europe?

A code for more transparency, effective 1st January 2018

A broad modification of the MedTech Europe "Code of Ethical Business Practice" has undergone a broad modification. This change is devised to regulate interaction between the industry and Healthcare professionals.

The Code concerns you especially if:

you are a physician / nurse / allied professional wishing to join EuroPCR 2018 and/or PCR London Valves 2018an industry partner willing to support delegate / faculty attendance. Get in touch with us!

New regulations, an opportunity for Industry Partners

As a trusted-third-party, Europa Group is fully committed to perpetuating long-term collaboration between industry partners and healthcare professionals. We are deeply involved in the matter of Educational Events for cardiovascular specialists and are willing to ensure that, as of 1st January 2018, industry partners can continue to take an active part in supporting practitioners’ attendance to our Courses.

Educational Allowances for practitioners

The new Code of Ethics introduced by MedTech Europe and echoed by regional counterparts (APACMed, Mecomed) is set to regulate interactions between industries and Healthcare Professionals. If you wish to access detailed information about the new Code, you might refer to the Ethical MedTech platform. 

What does this mean for practitioners?

Industry financial support for practitioners participation in educational events such as PCR Courses is transitioning from a direct to an indirect scheme. This means that since 1st January 2018 industry sponsorship will have to be indirectly allocated in the form of Educational Allowances via trusted-third-parties.